In AD cell models, MAGI2-AS3 can regulate MAGI2 mRNA levels, Aβ-induced neurotoxicity, and neuroinflammation through miR-374b-5p, suggesting that MAGI2-AS3 may be a potential therapeutic target for AD [134, 135]. Here, PDS5B is linked to Alzheimer disease.